There is a world-wide renaissance of neurosurgical treatments of Parki
nson's disease (PD), based on substantial progress in basic sciences.
A model of parallel motor circuitry has identified potential targets f
or lesioning by clarifying the pathophysiological role of the basal ga
nglia in PD. The internal globus pallidus (Gpi) is an essential player
as it connects to thalamocortical projections and can be disinhibited
by overactivity of the nucleus subthalamicus (Nst). Lesioning of thes
e targets has been successful in MPTP damaged primates. There is clini
cal use of destructive as well as restorative and stimulative technics
. Pallidotomy and thalamatomy have evolved by the use of better neuror
adiological and electrophysiological targeting. The first technic is u
sed for treatment of rigidity, hypokinesia and dyskinesias, the latter
one has proven to be efficient for tremor. Dopaminergic reinnervation
and increased dopaminergic output of the striatum has only been seen
after transplantation of fetal cells; this method however carries immu
nological and ethical problems. The continuous high frequency stimulat
ion of basal ganglia is the newest technic; it is highly adaptable to
the patient's need and carries a low morbidity profile. Thalamic stimu
lation is used for the treatment of tremor. The stimulation of Nst and
Gpi are proposed for dyskinesias and on/off phenomena. Animal researc
h further focuses on xenotransplantation and implantation of genetical
ly transformed cells or pluripotent precursor cells. - In summary neur
osurgical procedures seem to be verey promising; however longterm comp
arison studies are needed to define the best (combination) treatment(s
) for the future.